BRCA2 and breast cancer: In a recent study, Kuchenbaecker et al. [11] have reported that the 20-year cumulative risk for contralateral BC, after a first BC diagnosis, was 40% for germline BRCA1 PV carriers and 26% for germline BRCA2 PV carriers.